Juvenile Myelomonocytic Leukemia — Trials

Juvenile Myelomonocytic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

58 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 14
Recruiting: 9
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Masonic Cancer Center, University of Minnesota
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (6)

clinicaltrialsPublishedShowing 51–58 of 58 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01231919	MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia	completed	Phase 1	45	National Cancer Institute (NCI)NIH	2	Apr 29, 2014	clinicaltrials
NCT00697671	Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies	completed	Phase 1	48	St. Jude Children's Research HospitalOTHER	1	Jul 16, 2013	clinicaltrials